These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21694805)

  • 21. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Frackowiak M; Sharma M; Singh T; Mathew A; Michael BD
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD009027. PubMed ID: 31608991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of three patients with extensive neurocysticercosis in rural southern Tanzania: neurological, serological and neuroradiological findings.
    Stelzle D; Makasi C; Welte TM; Ruether C; Schmidt V; Gabriel S; Bottieau E; Fleury A; Ngowi BJ; Winkler AS;
    J Med Case Rep; 2023 Jul; 17(1):311. PubMed ID: 37408061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis.
    Wichert-Ana L; Velasco TR; Terra-Bustamante VC; Alexandre V; Walz R; Bianchin MM; Leite JP; Assirati JA; Carlotti CG; Araújo D; Santos AC; Takayanagui OM; Sakamoto AC
    Arch Neurol; 2004 Jul; 61(7):1117-9. PubMed ID: 15262746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.
    Zhu HX; Li YC; Yang XP; Chu YH; Guo W; Chen RX; Guo DD; Cheng LJ; Li Y
    Saudi J Med Med Sci; 2023; 11(4):283-291. PubMed ID: 37970452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocysticercosis.
    Garcia HH
    Neurol Clin; 2018 Nov; 36(4):851-864. PubMed ID: 30366559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversies in the treatment of seizures associated with neurocysticercosis.
    Singh G; Sharma R
    Epilepsy Behav; 2017 Nov; 76():163-167. PubMed ID: 28673685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Sharma M; Singh T; Mathew A
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.
    Monteiro L; Almeida-Pinto J; Stocker A; Sampaio-Silva M
    J Neurol; 1993 Nov; 241(1):15-21. PubMed ID: 8138816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reciprocal contribution of clinical studies and the HP10 antigen ELISA for the diagnosis of extraparenchymal neurocysticercosis.
    Parkhouse RME; Carpio A; Campoverde A; Sastre P; Rojas G; Cortez MM
    Acta Trop; 2018 Feb; 178():119-123. PubMed ID: 29155204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
    Thussu A; Chattopadhyay A; Sawhney IM; Khandelwal N
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):272-5. PubMed ID: 17928325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Ambispective Cohort Study to Assess Seizure Recurrences in Children with Calcified Parenchymal Neurocysticercosis.
    Modak A; Suthar R; Sharawat IK; Sankhyan N; Sahu JK; Malhi P; Khandelwal N
    Am J Trop Med Hyg; 2019 Oct; 101(4):812-820. PubMed ID: 31452498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single enhancing computerized tomography-detected lesion in immunocompetent patients.
    Garg RK
    Neurosurg Focus; 2002 Jun; 12(6):e4. PubMed ID: 15926783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocysticercosis.
    Singhi P; Suthar R
    Indian J Pediatr; 2015 Feb; 82(2):166-71. PubMed ID: 25297641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM; Velasco TR; Wichert-Ana L; Dos Santos AC; Sakamoto AC
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocysticercosis in non-endemic regions: The experience of Qatar.
    Haddad N; Shaheen Y; Abunaib M; Melikyan G; El Sotouhy A; Wahbeh F; Nauman A; Al-Maadid F; Soliman M; Mesraoua B; Elkhider H; Mahfoud Z
    Front Neurol; 2023; 14():1173909. PubMed ID: 37153684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible dementia as a presenting manifestation of racemose neurocysticercosis.
    Sharma S; Modi M; Lal V; Prabhakar S; Bhardwaj A; Sehgal R
    Ann Indian Acad Neurol; 2013 Jan; 16(1):88-90. PubMed ID: 23661971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation.
    Sharma LN; Garg RK; Verma R; Singh MK; Malhotra HS
    Seizure; 2013 Dec; 22(10):840-5. PubMed ID: 23880307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocysticercosis: Clinical Characteristics and Changes from 26 Years of Experience in an University Hospital in Korea.
    Son HJ; Kim MJ; Jung KH; Choi S; Jung J; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Jung BK; Song H; Chai JY
    Korean J Parasitol; 2019 Jun; 57(3):265-271. PubMed ID: 31284349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cysticidal Therapy for Diffuse Parenchymal and Calcific Neurocysticercosis.
    Agarwal A; Srivastava MVP; Gupta A; Rajan R; Garg A; Mishra B; Singh MB; Bhatia R; Vishnu VY
    Am J Trop Med Hyg; 2020 Nov; 104(2):734-738. PubMed ID: 33236706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Role of Surgery in the Treatment of Neurocysticercosis.
    Hamamoto Filho PT; Norcia LF; Fleury A; Zanini MA
    Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.